AI-assisted headline · Bariatric Surgery After Weight-Loss Drugs: What the Data Show
Original article title
Bariatric Surgery as a Rescue Strategy After Semaglutide or Tirzepatide.
Takeaway
Bariatric surgery was associated with substantial two-year weight loss after semaglutide or tirzepatide intolerance or inadequate response. Among poor medication responders, gastric bypass was associated with greater weight loss than sleeve gastrectomy, although treatment was not randomized.
Retrospective cohort; association, not causation.
The retrospective study reports weight loss after semaglutide or tirzepatide intolerance or inadequate response, without randomizing treatment or proving surgery is the right next step for everyone.
pubmed.ncbi.nlm.nih.gov · Full-text access depends on the publisher.
The short headline is AI-assisted and reviewed. The takeaway was checked against source text. The original title is preserved above.
This is a reading aid. Follow the source for methods, limitations, corrections, and clinical context.